Full Press Release Details
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
AMPH
Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz RANCHO CUCAMONGA, CA –
Key Takeaway: Amphastar Pharmaceuticals, Inc. Announces Settlement in Litigation with Momenta and Sandoz
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+29%
120-day peak, hindsight
Typical move
7.1%
average across 5 past catalysts
Lead asset
epinephrine
Phase 3 · Asthma